Patents by Inventor Jim MacMurry

Jim MacMurry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of oppositional defiant disorder and conduct disorder with 5-aminoalkyl-4,5,6,7-tetrahydro-4-oxyindolones
    Patent number: 6897212
    Abstract: A method for treating the psychiatric disorders known as oppositional defiant disorder and conduct disorder is disclosed. The method comprises the administration of a compound according to Formula I or II to a patient suffering from oppositional defiant disorder and/or conduct disorder. The compound may be either a racemic mixture or e.g. the levorotatory form. It may be short acting or in a sustained release, long acting form. Molindone or a pharmaceutically acceptable salt of molindone is a preferred embodiment.
    Type: Grant
    Filed: May 7, 2003
    Date of Patent: May 24, 2005
    Assignee: Afecta Pharmaceuticals
    Inventors: David E. Comings, Bruce Kovacs, Jim MacMurry
  • Treatment of oppositional defiant disorder and conduct disorder with 5-aminoalkyl-4,5,6,7-tetrahydro-4-oxyindolones
    Publication number: 20040116502
    Abstract: A method for treating the psychiatric disorders known as oppositional defiant disorder and conduct disorder is disclosed. The method comprises the administration of a compound according to Formula I or II to a patient suffering from oppositional defiant disorder and/or conduct disorder. The compound may be either a racemic mixture or e.g. the levorotatory form. It may be short acting or in a sustained release, long acting form. Molindone or a pharmaceutically acceptable salt of molindone is a preferred embodiment.
    Type: Application
    Filed: May 7, 2003
    Publication date: June 17, 2004
    Inventors: David E. Comings, Bruce Kovacs, Jim MacMurry
  • Use of molindone to treat oppositional defiant disorder and conduct disorder
    Patent number: 6613763
    Abstract: A method for treating the psychiatric disorders known as oppositional defiant disorder and conduct disorder is disclosed. The method comprises the administration of molindone or a pharmaceutically acceptable salt of molindone to a patient suffering from oppositional defiant disorder and/or conduct disorder. The molindone may be either a racemic mixture or the levorotatory form. It may be short acting or in a sustained release, long acting form.
    Type: Grant
    Filed: April 19, 2002
    Date of Patent: September 2, 2003
    Assignee: MGI Applied Genomics
    Inventors: David E. Comings, Bruce Kovacs, Jim MacMurry
  • USE OF MOLINDONE TO TREAT OPPOSITIONAL DEFIANT DISORDER AND CONDUCT DISORDER
    Publication number: 20020156078
    Abstract: A method for treating the psychiatric disorders known as oppositional defiant disorder and conduct disorder is disclosed. The method comprises the administration of molindone or a pharmaceutically acceptable salt of molindone to a patient suffering from oppositional defiant disorder and/or conduct disorder. The molindone may be either a racemic mixture or the levorotatory form. It may be short acting or in a sustained release, long acting form.
    Type: Application
    Filed: April 19, 2002
    Publication date: October 24, 2002
    Inventors: David E. Comings, Bruce Kovacs, Jim Macmurry